The anticancer effect of EGFR‐targeting artificial microRNA controlled by SLPI promoter in nasopharyngeal carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24729
Abstract: This study intends to use artificial microRNA (recombinant adenovirus vector) targeting epidermal growth factor receptor (EGFR) to inhibit the overexpressed EGFR in nasopharyngeal carcinoma, thereby inhibiting the proliferation and metastasis of nasopharyngeal carcinoma. read more here.
Keywords: nasopharyngeal carcinoma; anticancer effect; carcinoma; artificial microrna ... See more keywords